Flywheel reports record growth, launches products to support clinical trial and medical device markets, and closes $27.5M equity round
Minneapolis, MN — January 8, 2026 — Flywheel, the leading medical imaging data management and analysis platform, today announced key milestones achieved in 2025. The company also recently closed on an oversubscribed $25 million financing round, led by Novalis Lifesciences and 8VC. Flywheel has evolved from its origin as a technology platform designed to support core lab research to an enterprise imaging management platform designed to support clinical trials, medical device development and AI innovation through at-scale data aggregation, curation and…
Learn More